TickerFactsScreenerDevelopers

TherapeuticsMD, Inc. (TXMD) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2011: -$1.71M2012: -$1.43M2013: $54.70M2014: $48.39M2015: $63.06M2016: $127.49M2017: $129.91M2018: $97.52M2019: $9.20M2020: -$124.00M2021: -$93.62M2022: $35.14M2023: $29.29M2024: $27.37M2025: $26.88M$26.88M
2011Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$26.88M-1.8%
2024$27.37M-6.5%
2023$29.29M-16.7%
2022$35.14M+137.5%
2021-$93.62M+24.5%
2020-$124.00M-1447.7%
2019$9.20M-90.6%
2018$97.52M-24.9%
2017$129.91M+1.9%
2016$127.49M+102.2%
2015$63.06M+30.3%
2014$48.39M-11.5%
2013$54.70M+3916.7%
2012-$1.43M+16.3%
2011-$1.71M—